GlassScriptPhysician profile
Victoria A Pollander
NPI 1316400955
$548.97
in general payments reported to CMS, 2019-2025
10 companies · $206 in 2025
The $206 reported for 2025 was more than what 89% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.87 · 2023: $139 · 2024: $128 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $127.86 | 2021-2025 | Bridion |
| Aop Health US, LLC | $114.79 | 2025 | Rapiblyk |
| Qol Medical, LLC | $63.53 | 2023-2024 | Sucraid, Sucraid |
| Eagle Pharmaceuticals, INC. | $52.01 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.25 | 2023-2024 | Entyvio |
| Organon LLC | $42.56 | 2023-2024 | Hadlima, Renflexis |
| Janssen Biotech, INC. | $30.60 | 2025 | Tremfya |
| Edwards Lifesciences Corporation | $25.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $24.80 | 2024 | Dupixent |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Pollander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.